Q2 2021 InMed Pharmaceuticals Inc Earnings Call Transcript

Feb 11, 2021 / 04:30PM GMT
Operator

My name is [Annes], and I will be your conference operator today. At this time, I would like to welcome everyone to InMed's second-quarter 2021 financial results and business update conference call for the fiscal quarter ended December 30, 2020. (Operator Instructions) Thank you.

Mr. Payne, you may begin your conference. All lines have been placed on mute to prevent any background noise.

Brendan Payne - InMed Pharmaceuticals Inc. - Director of IR

Thank you, Annes. Good day, ladies and gentlemen. My name is Brendan Payne; I'm InMed's Director of Investor Relations. Welcome to InMed's second-quarter 2021 financial results and business update conference call. Please note our speakers are joining us today from remote locations, so we appreciate your patience if we encounter any unexpected technical challenges.

Before we begin, we would like to go over our disclosure statements, followed by a review of the progress on our therapeutic development and cannabinoid manufacturing programs, which will be led by our President and CEO, Eric Adams. Bruce

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot